Amir Shojaei sold $450K of Harrow (HROW)

Executed Aug 14, disclosed Aug 17, 3 days later.

Value, as filed

$450K

11,250 sh × $40.00

Executed

Aug 14

the trade date, as filed

Disclosed

Aug 17

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

AS Amir Shojaei CHIEF SCIENTIFIC OFFICER profile →

Amir Shojaei (CHIEF SCIENTIFIC OFFICER) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Harrow, Inc. (HROW). The largest single filing was $450K of HROW (11,250 sh × $40.00, as filed), executed Aug 14.

The name

HROW Harrow, Inc. HROW · Healthcare · 14 filings in 24 months ticker →

Healthcare · Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→